RankAlpha logo
Back to Rankings

MESO

MesoblastF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
MESO vs peer average
30/100
MESO vs. peer average (F vs. D)
Grade spread
B 2 · D 4 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

RXRX is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $1.92B

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerRXRXRecursion
MESO
Mesoblast
RXRX
Recursion
Grade
F
F
Momentum
24
14
Value
41
41
Sentiment
-
-
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs RXRX

MESO / RXRX
Grade Position
Below peers
MESO vs. peer average (F vs. D)
30/100
Momentum
24
MESO
Value
41
MESO
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs MESO
1
RXRX
Recursion Pharmaceuticals Inc Class A Common
F
20/100
Even
2
TRVI
Trevi Therapeutics Inc Common
D
40/100
-1
3
BHC
Bausch Health Companies Inc Common
D
40/100
-1
4
ABCL
AbCellera Biologics Inc Common
B
80/100
-3
5
ZLAB
Zai Lab Ltd ADR
F
20/100
Even
RXRX is the first peer returned for this comparison set.